These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 31420296

  • 1. Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
    Ma WJ, Wu ZR, Yang Q, Hu HJ, Wang JK, Shi YJ, Li FY, Cheng NS.
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):356-367. PubMed ID: 31420296
    [Abstract] [Full Text] [Related]

  • 2. Polymyxin and Bacitracin in the Irrigation Solution Provide No Benefit for Bacterial Killing in Vitro.
    Goswami K, Cho J, Foltz C, Manrique J, Tan TL, Fillingham Y, Higuera C, Della Valle C, Parvizi J.
    J Bone Joint Surg Am; 2019 Sep 18; 101(18):1689-1697. PubMed ID: 31567806
    [Abstract] [Full Text] [Related]

  • 3. Effective Treatment of Chronic Proliferative Cholangitis by Local Gentamicin Infusion in Rabbits.
    Yang Q, Wu Z, Liu F, Wang J, Ma W, Hu H, Li F, Pan Q.
    Biomed Res Int; 2018 Sep 18; 2018():6751952. PubMed ID: 30140699
    [Abstract] [Full Text] [Related]

  • 4. Macrophages and derived-TNF-α promote lipopolysaccharide-induced upregulation of endogenous β-glucuronidase in the epithelial cells of the bile duct: A possible facilitator of hepatolithiasis formation.
    Yang Y, Wang Y, Wang C, Wu S, Yao D.
    Clin Res Hepatol Gastroenterol; 2023 Jan 18; 47(1):102062. PubMed ID: 36473630
    [Abstract] [Full Text] [Related]

  • 5. Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.
    Li FY, Cheng NS, Mao H, Jiang LS, Cheng JQ, Li QS, Munireddy S.
    World J Surg; 2009 Oct 18; 33(10):2155-60. PubMed ID: 19641953
    [Abstract] [Full Text] [Related]

  • 6. Chlorhexidine Antiseptic Irrigation Eradicates Staphylococcus epidermidis From Biofilm: An In Vitro Study.
    Schmidt K, Estes C, McLaren A, Spangehl MJ.
    Clin Orthop Relat Res; 2018 Mar 18; 476(3):648-653. PubMed ID: 29443852
    [Abstract] [Full Text] [Related]

  • 7. Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis.
    Yang Q, Zhou Y, Li FY, Mao H, Shrestha A, Ma WJ, Cheng NS, Zhang W.
    Hepatobiliary Pancreat Dis Int; 2015 Oct 18; 14(5):509-15. PubMed ID: 26459727
    [Abstract] [Full Text] [Related]

  • 8. Practical value of applying cdc2 kinase shRNA to chronic proliferative cholangitis in treatment of hepatolithiasis.
    Li FY, Cheng NS, Cheng JQ, Mao H, Jiang LS, Li QS, Zhou Y.
    Hepatogastroenterology; 2009 Oct 18; 56(94-95):1477-82. PubMed ID: 19950813
    [Abstract] [Full Text] [Related]

  • 9. Comparison of 1-day versus 1-hour application of topical neomycin/polymyxin-B before cataract surgery.
    Li B, Miño de Kaspar H, Haritoglou C, Kook D, Kampik A, Sheng M, Nentwich MM.
    J Cataract Refract Surg; 2015 Apr 18; 41(4):724-31. PubMed ID: 25840297
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bacteriology and antimicrobial choice in hepatolithiasis.
    Sheen-Chen S, Chen W, Eng H, Sheen C, Chou F, Cheng Y, Lee T.
    Am J Infect Control; 2000 Aug 18; 28(4):298-301. PubMed ID: 10926707
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chronic proliferative cholangitis with c-myc shRNA.
    Li FY, Cheng NS, Cheng JQ, Mao H, Jiang LS, Li N, He S.
    World J Gastroenterol; 2009 Jan 07; 15(1):95-101. PubMed ID: 19115473
    [Abstract] [Full Text] [Related]

  • 14. Povidone iodine plus neosporin in superficial burns--a continuing study.
    Sinha R, Agarwal RK, Agarwal M.
    Burns; 1997 Jan 07; 23(7-8):626-8. PubMed ID: 9568337
    [Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide stimulates endogenous β-glucuronidase via PKC/NF-κB/c-myc signaling cascade: a possible factor in hepatolithiasis formation.
    Yao D, Dong Q, Tian Y, Dai C, Wu S.
    Mol Cell Biochem; 2018 Jul 07; 444(1-2):93-102. PubMed ID: 29188532
    [Abstract] [Full Text] [Related]

  • 16. EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR.
    Liu SH, Chen XF, Xie ZB, Zhou J.
    Int J Mol Med; 2019 Jul 07; 44(1):79-88. PubMed ID: 31115490
    [Abstract] [Full Text] [Related]

  • 17. Wound healing. The effects of topical antimicrobial agents.
    Geronemus RG, Mertz PM, Eaglstein WH.
    Arch Dermatol; 1979 Nov 07; 115(11):1311-4. PubMed ID: 507884
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis.
    Li F, Zhou Y, Cheng N, Mao H, Jiang L, Li N, Li Q, de Jong MC, Pawlik TM.
    J Surg Res; 2011 Mar 07; 166(1):87-94. PubMed ID: 20097367
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proliferating cell nuclear antigen shRNA treatment attenuates chronic proliferative cholangitis in rats.
    Li FY, Cheng NS, Cheng JQ, Mao H, Zhou Y, Jiang LS, Li N.
    J Gastroenterol Hepatol; 2009 May 07; 24(5):920-6. PubMed ID: 19032457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.